Use Auxilium Pharmaceuticals Inc. story with your portfolios to enhance returns of your portfolios as well as to determine Stock diversification method that is right for you.
This story from stocks.us.reuters.com contributed to next trading day price decline. The story delta to the next closing price was 0.05% . The story delta to the current price is 5.51% .
By DOW JONES NEWSWIRES Auxilium Pharmaceuticals Inc. (AUXL) raised its full-year outlook as it entered an agreement with the US unit of GlaxoSmithKline PLC (GSK) to co-promote a testosterone replacement therapy.
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co ...
MarketWatch (press release) - 10 hours ago
MALVERN, Pa. and PHILADELPHIA, May 21, 2012 /PRNewswire via COMTEX/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) and GlaxoSmithKline LLC, the US subsidiary of GlaxoSmithKline plc (LSS:UK:GSK) , announced today that they have entered into an ...
Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss ... - Sacramento Bee
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is accounting value of assets minus liabilities.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
